Aarogya Setu becomes open source app

▴ Aarogya Setu becomes open source app
Arogya Setu becomes open source with 115 million users

Arogya Setu, India's Covid-19 contact tracing, syndromic mapping, and self-assessment mobile app is now open source. Announcing it yesterday in New Delhi, NITI Aayog CEO Amitabh Kant said, transparency, privacy, and security have been the core design principles of Araogya Setu since it's inception and opening of the source code to the developer community signifies Government of India's continuing commitment to this principle. He said it is a unique thing as no other government product anywhere in the world has been open-sourced at this scale.

Mr Kant said, today the scale and size of Arogya Setu is 115 million and it cuts across every smart phone and IVRS in 12 languages. He said, in just 41 days the mobile app crossed 100 million. Our correspondent reports that  open sourcing an app’s code means the government will publish it on a public code repository. With the release of the source code in the public domain, Government is looking to expand collaboration and to leverage the expertise of top technical brains and also to collectively build a robust and secure technology solution to help support the work of frontline health workers in fighting this pandemic together.

On 2nd April, Government launched Aarogya Setu mobile App for helping augment the efforts of limiting the spread of COVID-19, with an objective of enabling Bluetooth based contact tracing, mapping of likely hotspots and dissemination of relevant information. The App has helped identify about 5 lakh Bluetooth contacts. Those who are identified as Bluetooth contacts of COVID19 positive cases or are classified as needing assistance based on their self-assessment, are contacted by National Health Authority. So far, the platform has reached out to more than 9 lakh users and helped advise them for Quarantine, caution, or testing.

Meanwhile, health Ministry has said that the recovery rate of patients from COVID-19 infection has now gone up to 41.61 percent which was 7.1 percent in March this year. Briefing media in New Delhi, Union Health Ministry official, Lav Agarwal said that the fatality rate due to coronavirus infection has come down from 3.30 percent to 2.87 percent, which is amongst the lowest in the world.

He said, due to the lockdown and containment measures taken by the government, 10.7 cases per lakh population have been reported in India as compared to 69.9 COVID-19 cases per lakh population for the world as a whole.

The official said 4.5 deaths per lakh population have been reported for the world, while India has reported about 0.3 deaths per lakh population, which is amongst the lowest in the world.


The Health Ministry official also appealed to people to maintain hand hygiene and social distancing and wear masks while stepping out. He said, there is a need to focus on prevention and containment measures to contain the spread of COVID19 infection. He said, about fifty percent of deaths reported among elderly people while 73 percent reported in the patients with comorbidity.

ICMR, Director General said that currently over one lakh samples for COVID-19 is being tested in a day. He said, the country has now 612 labs out of which 430 are government labs and 182 are private labs.

On the use of Hydroxychloroquine- HCQ drug, the ICMR DG said that HCQ has been widely used against malaria and considering its anti-viral properties, in-vitro study data, and availability and safety, ICMR had recommended it as a preventive treatment on a trial basis under supervision. He said, no major side-effects of HCQ have been found in studies in India except nausea and vomiting and its use should be continued in preventive treatment for COVID-19.

He said it has been clearly advised that HCQ should be taken with food, not on an empty stomach. He said, the ICMR also emphasized that one ECG should be done during the treatment. He said, it expanded the use of HCQ to frontline workers also, considering the potential benefits.

Tags : #AarogyaSetu #OpenSource #HCQ #LavAgarwal #ICMR

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026